Patents by Inventor Jenny E. Morgan

Jenny E. Morgan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FLOWABLE COLLAGEN-BASED HEMOSTAT AND METHODS OF USE
    Publication number: 20170258954
    Abstract: The invention relates to methods for fabricating a flowable hemostatic composition. The invention also relates to hemostatic compositions and methods for promoting wound healing. In various embodiments, the hemostatic compositions comprise crosslinkable collagen molecules having a porosity controlled by the ratio of weight percent collagen solids to weight percent crosslinker when crosslinking the collagen. In other embodiments, the hemostatic compositions comprise crosslinkable collagen molecules having a porosity controlled by the temperature and rate of freezing when drying the composition during fabrication. In some embodiments, the compositions contain additional agents, including biological agents.
    Type: Application
    Filed: May 26, 2017
    Publication date: September 14, 2017
    Inventors: Marissa M. Conrad, Lauren S. Valdes, Jenny E. Morgan, Alice Bachert, Abigail Cohen
  • Flowable collagen-based hemostat and methods of use
    Patent number: 9694101
    Abstract: The invention relates to methods for fabricating a flowable hemostatic composition. The invention also relates to hemostatic compositions and methods for promoting wound healing. In various embodiments, the hemostatic compositions comprise crosslinkable collagen molecules having a porosity controlled by the ratio of weight percent collagen solids to weight percent crosslinker when crosslinking the collagen. In other embodiments, the hemostatic compositions comprise crosslinkable collagen molecules having a porosity controlled by the temperature and rate of freezing when drying the composition during fabrication. In some embodiments, the compositions contain additional agents, including biological agents.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: July 4, 2017
    Assignee: Orthovita, Inc.
    Inventors: Marissa M. Conrad, Lauren S. Valdes, Jenny E. Morgan, Alice Bachert, Abigail Cohen